Jonathan Javitt - Apr 9, 2025 Form 4 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role: Chairman and Chief Scientist, Director, 10%+ Owner
Signature: /s/ Jonathan Javitt
Stock symbol: NRXP
Transactions as of: Apr 9, 2025
Transactions value $: $0
Form type: 4
Date filed: 9/10/2025, 03:36 PM
Previous filing: Dec 18, 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Javitt Jonathan C	Chairman and Chief Scientist, Director, 10%+ Owner	C/O NRX PHARMACEUTICALS, INC., 1201 ORANGE STREET, SUITE 600, WILMINGTON	/s/ Jonathan Javitt	2025-09-10	0001303782

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NRXP	Stock Option (right to buy)	Award	$0	+125K		$0.00	125K	Apr 9, 2025	Common Stock	125K	$1.73	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents stock options ("Options") granted pursuant to the Issuer's 2021 Omnibus Incentive Plan. 1/3 of the Options shall vest on the first anniversary of the grant date, with the remainder vesting in twenty-four equal monthly installments thereafter, subject to continued